RELATED PARTY TRANSACTIONS (Details) - USD ($)	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Related Party Transactions [Abstract]
Due to (from) related parties at beginning of period	$ 920,782	$ (101,297)
Amounts invoiced by Pharma to DDL, NM and TCL primarily relating to research and development expenses	2,907,192	1,833,706
Amounts invoiced by DDL to Pharma	0	(2,437)
Amounts paid by DDL to Pharma	(3,735,011)	(1,695,999)
Foreign exchange differences	2,834	88,408
Due to (from) related parties at end of period	$ 95,797	$ 122,381